Ultralife Corporation Statistics
Share Statistics
Ultralife Corporation has 16.63M shares outstanding. The number of shares has increased by 1.73% in one year.
Shares Outstanding | 16.63M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.01% |
Owned by Institutions (%) | n/a |
Shares Floating | 10.12M |
Failed to Deliver (FTD) Shares | 2.07K |
FTD / Avg. Volume | 3.21% |
Short Selling Information
The latest short interest is 173.06K, so 1.04% of the outstanding shares have been sold short.
Short Interest | 173.06K |
Short % of Shares Out | 1.04% |
Short % of Float | 1.71% |
Short Ratio (days to cover) | 2.95 |
Valuation Ratios
The PE ratio is 15.5 and the forward PE ratio is 8.9. Ultralife Corporation's PEG ratio is 0.17.
PE Ratio | 15.5 |
Forward PE | 8.9 |
PS Ratio | 0.7 |
Forward PS | 0.7 |
PB Ratio | 0.89 |
P/FCF Ratio | -179.06 |
PEG Ratio | 0.17 |
Enterprise Valuation
Ultralife Corporation has an Enterprise Value (EV) of 129.46M.
EV / Earnings | 17.99 |
EV / Sales | 0.82 |
EV / EBITDA | 9.67 |
EV / EBIT | 13.66 |
EV / FCF | -207.81 |
Financial Position
The company has a current ratio of 3.8, with a Debt / Equity ratio of 0.2.
Current Ratio | 3.8 |
Quick Ratio | 2.02 |
Debt / Equity | 0.2 |
Total Debt / Capitalization | 16.97 |
Cash Flow / Debt | 0.08 |
Interest Coverage | 4.7 |
Financial Efficiency
Return on equity (ROE) is 0.06% and return on capital (ROIC) is 4.82%.
Return on Equity (ROE) | 0.06% |
Return on Assets (ROA) | 0.04% |
Return on Capital (ROIC) | 4.82% |
Revenue Per Employee | 295.98K |
Profits Per Employee | 13.43K |
Employee Count | 536 |
Asset Turnover | 0.89 |
Inventory Turnover | 2.83 |
Taxes
Income Tax | 1.95M |
Effective Tax Rate | 0.21 |
Stock Price Statistics
The stock price has increased by 8.32% in the last 52 weeks. The beta is 0.98, so Ultralife Corporation's price volatility has been higher than the market average.
Beta | 0.98 |
52-Week Price Change | 8.32% |
50-Day Moving Average | 8.36 |
200-Day Moving Average | 9.8 |
Relative Strength Index (RSI) | 47.48 |
Average Volume (20 Days) | 64.56K |
Income Statement
In the last 12 months, Ultralife Corporation had revenue of $158.64M and earned $7.20M in profits. Earnings per share was $0.44.
Revenue | 158.64M |
Gross Profit | 39.20M |
Operating Income | 9.47M |
Net Income | 7.20M |
EBITDA | 13.39M |
EBIT | 9.47M |
Earnings Per Share (EPS) | 0.44 |
Balance Sheet
The company has $10.28M in cash and $29.16M in debt, giving a net cash position of -$18.88M.
Cash & Cash Equivalents | 10.28M |
Total Debt | 29.16M |
Net Cash | -18.88M |
Retained Earnings | -40.75M |
Total Assets | 172.44M |
Working Capital | 60.23M |
Cash Flow
In the last 12 months, operating cash flow was $1.93M and capital expenditures -$2.55M, giving a free cash flow of -$623.00K.
Operating Cash Flow | 1.93M |
Capital Expenditures | -2.55M |
Free Cash Flow | -623.00K |
FCF Per Share | -0.04 |
Margins
Gross margin is 24.71%, with operating and profit margins of 5.97% and 4.54%.
Gross Margin | 24.71% |
Operating Margin | 5.97% |
Pretax Margin | 5.75% |
Profit Margin | 4.54% |
EBITDA Margin | 8.44% |
EBIT Margin | 5.97% |
FCF Margin | -0.39% |
Dividends & Yields
ULBI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 5.63% |
FCF Yield | -0.48% |
Analyst Forecast
The average price target for ULBI is $14, which is 79.3% higher than the current price. The consensus rating is "Buy".
Price Target | $14 |
Price Target Difference | 79.3% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Scores
Altman Z-Score | 3.43 |
Piotroski F-Score | 6 |